Dirui Industrial Co.,Ltd. (300396.SZ)
CNY 13.0
(1.17%)
CNY 13.0
(1.17%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 1.36 Billion CNY | 11.75% |
| 2022 | 1.22 Billion CNY | 34.69% |
| 2021 | 905.79 Million CNY | -3.35% |
| 2020 | 937.23 Million CNY | -7.09% |
| 2019 | 1 Billion CNY | 8.07% |
| 2018 | 933.41 Million CNY | 7.58% |
| 2017 | 867.69 Million CNY | 14.37% |
| 2016 | 758.69 Million CNY | 33.73% |
| 2015 | 567.32 Million CNY | 16.62% |
| 2014 | 486.47 Million CNY | 4.75% |
| 2013 | 464.4 Million CNY | 12.27% |
| 2012 | 413.63 Million CNY | 15.52% |
| 2011 | 358.05 Million CNY | 54.88% |
| 2010 | 231.18 Million CNY | 31.62% |
| 2009 | 175.64 Million CNY | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 213.61 Million CNY | -67.59% |
| 2024 Q3 | 297.17 Million CNY | 39.12% |
| 2024 Q1 | 659.02 Million CNY | 103.31% |
| 2023 Q1 | 331.93 Million CNY | -20.52% |
| 2023 Q3 | 353.66 Million CNY | -2.57% |
| 2023 Q2 | 363 Million CNY | 9.36% |
| 2023 FY | 1.36 Billion CNY | 11.75% |
| 2023 Q4 | 324.14 Million CNY | -8.35% |
| 2022 Q3 | 287.55 Million CNY | -0.26% |
| 2022 Q2 | 288.28 Million CNY | 27.27% |
| 2022 FY | 1.22 Billion CNY | 34.69% |
| 2022 Q4 | 417.65 Million CNY | 45.25% |
| 2022 Q1 | 226.51 Million CNY | -16.89% |
| 2021 Q2 | 219.05 Million CNY | 10.31% |
| 2021 Q1 | 198.57 Million CNY | -10.51% |
| 2021 FY | 905.79 Million CNY | -3.35% |
| 2021 Q4 | 272.53 Million CNY | 26.38% |
| 2021 Q3 | 215.63 Million CNY | -1.56% |
| 2020 Q2 | 290.15 Million CNY | 67.78% |
| 2020 Q4 | 221.9 Million CNY | -12.03% |
| 2020 Q3 | 252.23 Million CNY | -13.07% |
| 2020 FY | 937.23 Million CNY | -7.09% |
| 2020 Q1 | 172.93 Million CNY | -37.39% |
| 2019 Q4 | 276.23 Million CNY | 15.6% |
| 2019 FY | 1 Billion CNY | 8.07% |
| 2019 Q3 | 238.95 Million CNY | -8.0% |
| 2019 Q2 | 259.72 Million CNY | 11.05% |
| 2019 Q1 | 233.87 Million CNY | -12.06% |
| 2018 Q2 | 249.45 Million CNY | 31.74% |
| 2018 Q1 | 189.35 Million CNY | -27.15% |
| 2018 FY | 933.41 Million CNY | 7.58% |
| 2018 Q4 | 265.94 Million CNY | 16.31% |
| 2018 Q3 | 228.65 Million CNY | -8.34% |
| 2017 FY | 867.69 Million CNY | 14.37% |
| 2017 Q1 | 154.62 Million CNY | -37.25% |
| 2017 Q2 | 241.68 Million CNY | 56.3% |
| 2017 Q3 | 211.44 Million CNY | -12.51% |
| 2017 Q4 | 259.93 Million CNY | 22.93% |
| 2016 Q3 | 176.9 Million CNY | -8.68% |
| 2016 FY | 758.69 Million CNY | 33.73% |
| 2016 Q1 | 141.66 Million CNY | -30.06% |
| 2016 Q2 | 193.71 Million CNY | 36.74% |
| 2016 Q4 | 246.4 Million CNY | 39.28% |
| 2015 Q3 | 138.27 Million CNY | 6.58% |
| 2015 Q4 | 202.56 Million CNY | 46.5% |
| 2015 Q2 | 129.74 Million CNY | 34.11% |
| 2015 Q1 | 96.74 Million CNY | -35.56% |
| 2015 FY | 567.32 Million CNY | 16.62% |
| 2014 Q2 | 119.6 Million CNY | 28.66% |
| 2014 Q1 | 92.95 Million CNY | -29.91% |
| 2014 Q4 | 150.13 Million CNY | 21.29% |
| 2014 Q3 | 123.78 Million CNY | 3.49% |
| 2014 FY | 486.47 Million CNY | 4.75% |
| 2013 Q3 | 121.07 Million CNY | 0.0% |
| 2013 FY | 464.4 Million CNY | 12.27% |
| 2013 Q4 | 132.63 Million CNY | 9.54% |
| 2012 FY | 413.63 Million CNY | 15.52% |
| 2011 FY | 358.05 Million CNY | 54.88% |
| 2010 FY | 231.18 Million CNY | 31.62% |
| 2009 FY | 175.64 Million CNY | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Dian Diagnostics Group Co.,Ltd. | 13.4 Billion CNY | 89.832% |
| Hangzhou Tigermed Consulting Co., Ltd. | 7.38 Billion CNY | 81.537% |
| Beijing Strong Biotechnologies, Inc. | 1.74 Billion CNY | 21.721% |
| Medicalsystem Biotechnology Co., Ltd. | 1.88 Billion CNY | 27.709% |
| Maccura Biotechnology Co.Ltd | 2.89 Billion CNY | 52.92% |
| Guangzhou Wondfo Biotech Co.,Ltd | 2.76 Billion CNY | 50.692% |
| Guangdong Hybribio Biotech Co.,Ltd. | 1.1 Billion CNY | -23.438% |
| BGI Genomics Co., Ltd. | 4.34 Billion CNY | 68.657% |
| Amoy Diagnostics Co., Ltd. | 1.03 Billion CNY | -31.235% |
| Shanghai Labway Clinical Laboratory Co., Ltd. | 1.67 Billion CNY | 18.577% |